New Market Study, "Lab21 Limited - Product Pipeline Analysis, 2013 Update", Has Been Published
Lab21 Limited (Lab21) is a healthcare service provider. The company offers diagnostic products and services, and supports medical diagnostics, blood bank screening and drug discovery. Its diagnostic product division manufactures immuno-diagnostic kits and reagents to treat infectious diseases for the blood banking and clinical markets. Lab21 serves pharmaceutical and diagnostic firms and international healthcare providers. The company operates through its offices in the US, and the UK with a GMP manufacturing facility in Cambridge and other manufacturing sites in Camberley,...
View full press release